475 related articles for article (PubMed ID: 17685413)
21. Bispyridinium oximes as antidotal treatment of cyclosarin poisoning-in vitro and in vivo testing.
Bartosova L; Kuca K; Jun D; Kunesova G
Int J Toxicol; 2005; 24(6):399-402. PubMed ID: 16393932
[TBL] [Abstract][Full Text] [Related]
22. Neuroprotective effects of currently used antidotes in tabun-poisoned rats.
Kassa J; Krejèová G
Pharmacol Toxicol; 2003 Jun; 92(6):258-64. PubMed ID: 12787257
[TBL] [Abstract][Full Text] [Related]
23. A comparison of reactivating and therapeutic efficacy of bispyridinium acetylcholinesterase reactivator KR-22934 with the oxime K203 and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
Kassa J; Karasova JZ; Pavlikova R; Musilek K; Kuca K; Bajgar J; Jung YS
Toxicol Mech Methods; 2011 Mar; 21(3):241-5. PubMed ID: 21142778
[TBL] [Abstract][Full Text] [Related]
24. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.
Kuca K; Cabal J; Kassa J
Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060
[TBL] [Abstract][Full Text] [Related]
25. A comparison of the reactivating and therapeutic efficacy of two novel bispyridinium oximes (K727, K733) with the oxime HI-6 and obidoxime in sarin-poisoned rats and mice.
Kassa J; Sepsova V; Matouskova L; Horova A; Musilek K
Toxicol Mech Methods; 2015 Mar; 25(3):229-33. PubMed ID: 25894563
[TBL] [Abstract][Full Text] [Related]
26. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of tabun poisoning in rats and mice.
Kassa J; Karasova JZ; Pavlikova R; Misik J; Caisberger F; Bajgar J
J Appl Toxicol; 2010 Mar; 30(2):120-4. PubMed ID: 19746406
[TBL] [Abstract][Full Text] [Related]
27. The benefit of combination of oximes for the neuroprotective efficacy of antidotal treatment of sarin-poisoned rats.
Kassa J; Kunesova G
Toxicol Mech Methods; 2012 May; 22(4):260-7. PubMed ID: 22149934
[TBL] [Abstract][Full Text] [Related]
28. The development of new oximes and the evaluation of their reactivating, therapeutic and neuroprotective efficacy against tabun.
Kassa J; Kuca K; Karasova J; Musilek K
Mini Rev Med Chem; 2008 Oct; 8(11):1134-43. PubMed ID: 18855728
[TBL] [Abstract][Full Text] [Related]
29. [Comparison of the reactivating effect of BI-6, a new asymmetrical bispyridinium oxime, with oxime HI-6 and obidoxime on soman-inhibited acetylcholinesterase in the diaphragm and various parts of the brain in rats].
Kassa J; Bajgar J
Cas Lek Cesk; 1999 Aug; 138(17):532-5. PubMed ID: 10566233
[TBL] [Abstract][Full Text] [Related]
30. In vitro reactivating effects of standard and newly developed oximes on malaoxon-inhibited mouse brain acetylcholinesterase.
dos Santos AA; dos Santos DB; Dafre AL; de Bem AF; Souza DO; da Rocha JB; Kuca K; Farina M
Basic Clin Pharmacol Toxicol; 2010 Sep; 107(3):768-73. PubMed ID: 20406208
[TBL] [Abstract][Full Text] [Related]
31. A comparison of the potency of the oxime HLö-7 and currently used oximes (HI-6, pralidoxime, obidoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods.
Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M
Acta Medica (Hradec Kralove); 2005; 48(2):81-6. PubMed ID: 16259317
[TBL] [Abstract][Full Text] [Related]
32. A comparison of the potency of newly developed oximes (K347, K628) and currently available oximes (obidoxime, HI-6) to counteract acute neurotoxic effects of Tabun in rats.
Kassa J; Karasová JZ; Tesarová S; Musílek K; Kuca K
Acta Medica (Hradec Kralove); 2010; 53(2):85-91. PubMed ID: 20672744
[TBL] [Abstract][Full Text] [Related]
33. The reactivating and therapeutic efficacy of oximes to counteract Russian VX poisonings.
Kassa J; Jun D; Kuca K
Int J Toxicol; 2006; 25(5):397-401. PubMed ID: 16940011
[TBL] [Abstract][Full Text] [Related]
34. Current understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning.
Jokanović M; Stojiljković MP
Eur J Pharmacol; 2006 Dec; 553(1-3):10-7. PubMed ID: 17109842
[TBL] [Abstract][Full Text] [Related]
35. Effects of K074 and pralidoxime on antioxidant and acetylcholinesterase response in malathion-poisoned mice.
dos Santos AA; dos Santos DB; Ribeiro RP; Colle D; Peres KC; Hermes J; Barbosa AM; Dafré AL; de Bem AF; Kuca K; Farina M
Neurotoxicology; 2011 Dec; 32(6):888-95. PubMed ID: 21723318
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the potency of two novel bispyridinium oximes (K456, K458) in comparison with oxime K203 and trimedoxime to counteract tabun-induced neurotoxicity in rats.
Kassa J; Misik J; Karasova JZ
Basic Clin Pharmacol Toxicol; 2013 Sep; 113(3):201-8. PubMed ID: 23647829
[TBL] [Abstract][Full Text] [Related]
37. Comparison of reactivating and therapeutic efficacy of two salts of the oxime HI-6 against tabun, soman and cyclosarin in rats.
Kassa J; Jun D; Kuca K; Bajgar J
Basic Clin Pharmacol Toxicol; 2007 Nov; 101(5):328-32. PubMed ID: 17910616
[TBL] [Abstract][Full Text] [Related]
38. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of soman poisoning in rats and mice.
Kassa J; Karasova JZ; Caisberger F; Bajgar J
Toxicol Mech Methods; 2009 Nov; 19(9):547-51. PubMed ID: 19839724
[TBL] [Abstract][Full Text] [Related]
39. Some benefit from non-oximes MB408, MB442 and MB444 in combination with the oximes HI-6 or obidoxime and atropine in antidoting sarin or cyclosarin poisoned mice.
Kassa J; Timperley CM; Bird M; Williams RL; Green AC; Tattersall JEH
Toxicology; 2018 Sep; 408():95-100. PubMed ID: 30005893
[TBL] [Abstract][Full Text] [Related]
40. Neuroprotective effects of currently used antidotes in soman-poisoned rats.
Kassa J; Koupilová M
Pharmacol Biochem Behav; 2000 Nov; 67(3):663-8. PubMed ID: 11164099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
